170 related articles for article (PubMed ID: 35690080)
1. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
[TBL] [Abstract][Full Text] [Related]
2. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
3. Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro/SSA antibody positive pregnancy.
Miyasato-Isoda M; Waguri M; Yamada Y; Miyano A; Wada Y
Mod Rheumatol; 2018 Jul; 28(4):690-696. PubMed ID: 28880700
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.
Buyon JP; Masson M; Izmirly CG; Phoon C; Acherman R; Sinkovskaya E; Abuhamad A; Makhoul M; Satou G; Hogan W; Pinto N; Moon-Grady A; Howley L; Donofrio M; Krishnan A; Ahmadzia H; Levasseur S; Paul E; Owens S; Cumbermack K; Matta J; Joffe G; Lindblade C; Haxel C; Kohari K; Copel J; Strainic J; Doan T; Bermudez-Wagner K; Holloman C; Sheth SS; Killen S; Tacy T; Kaplinski M; Hornberger L; Carlucci PM; Izmirly P; Fraser N; Clancy RM; Cuneo BF
Arthritis Rheumatol; 2024 Mar; 76(3):411-420. PubMed ID: 37947364
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of adverse neonatal outcomes in pregnant women with positive anti-Ro/SSA and anti-La/SSB antibodies].
Zhang MY; Sun X
Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):804-810. PubMed ID: 37981765
[No Abstract] [Full Text] [Related]
6. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
[TBL] [Abstract][Full Text] [Related]
7. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
[TBL] [Abstract][Full Text] [Related]
8. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
9. Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.
Chen YL; Hu CJ; Peng LY; Wang CH; Zhao Y; Zhang W; Liu DZ;
J Clin Lab Anal; 2021 Dec; 35(12):e24045. PubMed ID: 34674312
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
[TBL] [Abstract][Full Text] [Related]
12. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease.
Cuneo BF; Fruitman D; Benson DW; Ngan BY; Liske MR; Wahren-Herlineus M; Ho SY; Jaeggi E
Am J Cardiol; 2011 Mar; 107(5):761-6. PubMed ID: 21247531
[TBL] [Abstract][Full Text] [Related]
14. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
[TBL] [Abstract][Full Text] [Related]
15. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
[TBL] [Abstract][Full Text] [Related]
16. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.
Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE
Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
[TBL] [Abstract][Full Text] [Related]
20. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
